Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
about
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesDevelopment of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implicationsCX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerStructure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101FHost cytoskeleton in respiratory syncytial virus assembly and buddingEGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionRequirements for Human Respiratory Syncytial Virus Glycoproteins in Assembly and Egress from Infected Cells.Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cellsThe cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production.Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus.Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressureConserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responsesThe cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinEffects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infectionInfection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesCross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production.Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducksAnimal pneumoviruses: molecular genetics and pathogenesis.Small hydrophobic protein of human metapneumovirus does not affect virus replication and host gene expression in vitroThe central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.Structure and function of respiratory syncytial virus surface glycoproteins.Virus replication in engineered human cells that do not respond to interferons.A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virusA live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuationThe baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteinsThe cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein.Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection.Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.Identification of deletion mutant respiratory syncytial virus strains lacking most of the G protein in immunocompromised children with pneumonia in South Africa.Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.
P2860
Q24815873-9778943C-EB20-48C5-9B6C-81F4028D0798Q26782411-0DB83739-2D86-4A1A-AE77-41281F3EA5BDQ26991548-CDDA2E02-612B-40C0-83BA-2EFA1CF59146Q27303940-DAB8C081-C49F-4336-815C-A21EA05756A6Q27664797-5DB651A7-E167-4624-9F2D-BE43DD9C7C2EQ28067634-1B8D21AD-FEDD-41F6-B238-D5FC848314FBQ28551865-61D61963-2247-4918-A9B1-08A5F559BC69Q30430684-40C6E2DE-26BA-45B5-9F92-BDDF06DD4F19Q30440160-BF7E89EF-DB95-4719-ACC5-D5DFEF4BE558Q30441394-582DB982-F0DE-4D2B-88AE-66985E77E146Q33396977-81162E19-EC72-4356-8060-4157A60A98A7Q33744060-A025D58C-5ECE-4A62-9802-BD456BA8E760Q33754172-70FEF40B-1BF2-4525-9C75-C827493C8F98Q33863111-6738533B-6DAB-498C-BDDA-00A89741785DQ33881536-29A24595-85F2-4241-A473-96CE1B136025Q33984333-7051AD84-878F-4755-925D-48AE4AE2C098Q34082711-5AF98C20-2612-4DE8-AC73-185048503871Q34102261-B8403C30-D964-471A-B6F4-11251689AB04Q34120191-6161229D-BF1C-4574-BEF3-E2747D595C53Q34151000-AC539A2D-58AB-4580-909A-A6BED42A7DDCQ34151865-B922E5BB-93F0-427A-9A4B-52D791EEB5FEQ34256243-5A37CC4D-014E-428A-A542-C72CFDFD755FQ34313560-9C7597F1-32FD-4F1D-BD5E-9B0D2CC39186Q34332549-89097950-AC87-4FBD-AB3B-879C976317DFQ34340452-6AAEF914-E20E-4CC5-AF88-42331172040AQ34353365-B5404A50-0F5B-414E-8C20-C09BBD486623Q34414405-B5F75AAE-486C-4AFB-BBF1-2D457F060101Q34468082-F4EAA100-945D-4F80-B87D-719CB1D461BDQ34542805-FF13A043-4797-4A61-ADE3-E3F50C11E8A5Q34547769-2D017A7F-AAB2-4EFC-83DE-B8F472833936Q34553841-FAAA2238-7F01-4E9C-B43D-A274618C02F9Q34651258-00F76A3A-19CC-4D4F-A36F-2BE9E3C3C8B2Q34744464-D8AA5741-B931-451C-B2A5-BB2086391F1AQ34825946-1CC2B2FE-C75E-49B6-8223-171021941CB6Q34908895-9691A933-B4A8-4527-8628-C9DCAF4B5CD4Q35140383-8E441C50-8645-4FA2-822C-AF38BDC330BCQ35192881-B78F6740-4187-457F-841C-96D80D3500BEQ35217016-574FBE76-3967-453F-B138-26F480886785Q35222083-BE399EDA-3D27-40E7-AC95-C1B289D127A9Q35273655-F2594E77-CF04-4D4A-B224-DFE483AE4268
P2860
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Contribution of the respirator ...... lication in vitro and in vivo.
@en
type
label
Contribution of the respirator ...... lication in vitro and in vivo.
@en
prefLabel
Contribution of the respirator ...... lication in vitro and in vivo.
@en
P2093
P356
P1433
P1476
Contribution of the respirator ...... lication in vitro and in vivo.
@en
P2093
P304
P356
10.1006/VIRO.2001.1138
P407
P577
2001-10-01T00:00:00Z